ALZAMEND NEURO INC. -

0.7600

15-April-25 16:45:00

15 minutes delayed

Stocks

-0.0290

-3.68%

Today's range

0.7592 - 0.8220

ISIN

N/A

Source

NASDAQ

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

25 Mar 2025 08:00:01 By Nasdaq GlobeNewswire
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

18 Mar 2025 08:00:00 By Nasdaq GlobeNewswire
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

11 Mar 2025 08:00:00 By Nasdaq GlobeNewswire
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

04 Mar 2025 08:10:00 By Nasdaq GlobeNewswire
Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

25 Feb 2025 08:00:59 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.